QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes
NEW YORK, March 6 /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on March 11, 2008, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) will replace Respironics Inc. (NASDAQ:RESP) in the HealthShares(TM) Composite Index. Dr. Reddy's Laboratories Ltd (NYSE:RDY) will replace Respironics in the HealthShares(TM) Respiratory/Pulmonary Index. Respironics is being acquired by Koninklijke Phillips Electronics NV (NYSE:PHG).
The HealthShares(TM) Composite Index consists of the 80 largest companies by market capitalization that are engaged in healthcare, life sciences and/or biotechnology that are part of the 16 underlying HealthShares Indexes, selecting the top 5 companies in market capitalization from each of the Composite Eligible Indexes. Companies included in the HealthShares(TM) Respiratory/Pulmonary Index are engaged in the research, development, and/or commercialization of therapeutic agents treating various respiratory and/or pulmonary diseases including, but not limited to, asthma, chronic obstructive pulmonary disease, emphysema, tuberculosis and pulmonary arterial hypertension.
About QED International Associates QED International Associates, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at www.qedinternational.com First Call Analyst:
CONTACT: Ed Matluck, CEO, ematluck@qedinternational.com, or Michael Web site: http://www.qedinternational.com/
2008-03-06 18:07:59 0306897 PRNEWSWIRE
HOME || Press Release Archive || © Leigh Media Corporation || Terms of Use || Privacy Policy || Publish Your Press Release Here |